EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GDF10 exacerbates metastatic burden and cachexia in murine models of cancer

Lauren S James, Alastair A E Saunders, Chris Karagiannis, Hongwei Qian, Robin L Anderson, Rachel E Thomson, Craig A Goodman, Paul Gregorevic

Frontiers in Physiology · 24.04.2026 · 17

DOI: 10.3389/fphys.2026.1773275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 24.04.2026. Verfasst von Lauren S James und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Muscle Research, and Department of Anatomy and Physiology, The University of Melbourne, Parkville, VIC, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Tour de Cure, Cass Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis and cancer-induced cachexia significantly reduce survivorship and quality of life for cancer patients. GDF10 (BMP3b) is a TGF-ß superfamily ligand with little knowledge of its role in cancer progression. Some studies have shown that GDF10 exerts tumor-suppressive effects in a range of cancer types and also plays a protective role against muscle wasting. Basal transcription of GDF10 was described previously to be downregulated in both primary tumors and cachectic muscle. Here, we set out to investigate the therapeutic potential of GDF10 in the 4T1.2 mouse model of breast cancer metastasis and in the C-26 mouse model of cancer cachexia, hypothesizing that GDF10 would ameliorate both metastatic and cachectic disease pathology. Systemic rAAV6:GDF10 administration to mice did not alter primary tumor growth; however, metastatic burden was increased in the mice bearing 4T1.2 tumors. Similarly, increased intramuscular rAAV6:GDF10 expression exacerbated skeletal muscle wasting in C-26 tumor-bearing mice. These results contradicted our initial hypothesis and highlight the complexity of signaling mechanisms utilized by BMP family ligands. Our data point to the need for more research to understand how to target GDF10 in anti-cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

BMP3bGDF10adeno-associated viruscachexiacancermetastasisskeletal muscle

Autor:innen und Institutionen

  • Centre for Muscle Research, and Department of Anatomy and Physiology, The University of Melbourne, Parkville, VIC, Australia.
  • Metastasis Research Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.
  • School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.
  • Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia.
  • Department of Neurology, The University of Washington School of Medicine, Seattle, WA, United States.

Förderung

  • National Health and Medical Research Council
  • Tour de Cure
  • Cass Foundation

Zitieren

APA

James, L. S., Saunders, A. A. E., Karagiannis, C., Qian, H., Anderson, R. L., Thomson, R. E., Goodman, C. A., & Gregorevic, P. (2026). GDF10 exacerbates metastatic burden and cachexia in murine models of cancer. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1773275

Vancouver

James LS, Saunders AAE, Karagiannis C, Qian H, Anderson RL, Thomson RE, et al. GDF10 exacerbates metastatic burden and cachexia in murine models of cancer. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1773275

BibTeX
@article{James2026,
  author = {James, Lauren S and Saunders, Alastair A E and Karagiannis, Chris and Qian, Hongwei and Anderson, Robin L and Thomson, Rachel E and Goodman, Craig A and Gregorevic, Paul},
  title = {GDF10 exacerbates metastatic burden and cachexia in murine models of cancer},
  journal = {Frontiers in Physiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphys.2026.1773275}
}
Kostenlos starten →